Phase I and pharmacokinetic study of docetaxel combined with melphalan and carboplatin, with autologous hematopoietic progenitor cell support, in patients with advanced refractory malignancies
Keywords: فارماکودینامیک; High-dose chemotherapy; Docetaxel; Autologous transplantation; Pharmacokinetics; Pharmacodynamics; Phase I trial;